⭐ High Conviction Short-Term Pick
⭐ Today’s Highest Conviction Stock
⭐⭐⭐⭐⭐ TTK Healthcare Ltd.
TTK Healthcare is a promising 4–6 week swing and delivery candidate. Its short- and medium-term trends are bullish, momentum remains healthy and the price is trading above every major moving average. RSI is within the preferred range and ADX confirms strong trend strength without the stock becoming excessively overheated.
Chanakya Quick Decision Box
| Rating | Value |
|---|---|
| Conviction | ⭐⭐⭐⭐⭐ |
| Holding Period | 4–6 weeks |
| Expected Potential | 8–14% |
| Risk | Medium |
| Suitable For | Swing and Delivery |
| CMP | Rs. 1,159.70 |
Trade Setup
| Strategy | Entry | Targets | Stop Loss |
|---|---|---|---|
| Buy on declines | Rs. 1,138–1,155 | Rs. 1,205 / Rs. 1,249 | Rs. 1,104 |
| Breakout buy | Above Rs. 1,168 | Rs. 1,249 / Rs. 1,286 | Rs. 1,137 |
| Extended target | After Rs. 1,249 breakout | Rs. 1,317 | Trail upward |
| Exit signal | Below Rs. 1,104 | Avoid fresh buying | — |
Investors should accumulate gradually rather than deploy the entire amount at one price. A breakout entry is preferable only if the stock sustains above Rs. 1,168 with improving volume.
Why This Trade?
TTK Healthcare closed at Rs. 1,159.70, gaining a controlled 2.25% in one session. It has advanced 4.23% over one week, 13.20% in one month and 30.03% in three months. This price behaviour indicates sustained accumulation without the excessive one-day appreciation seen in many overheated momentum counters.
The stock is trading above its 20-day SMA of Rs. 1,100.69, 34-day SMA of Rs. 1,068.97 and 50-day SMA of Rs. 1,024.64. It is also comfortably above the 89-day and 200-day averages, confirming substantial improvement in the broader price structure.
Trend Analysis
| Trend | View |
|---|---|
| Short term—5 days | 🟢 Bullish |
| Medium term—21 days | 🟢 Bullish |
| Long term—63 days | 🟡 Bearish but improving |
The long-term trend indicator has not yet formally turned bullish. However, the stock’s position above its 200-day SMA of Rs. 968.68 suggests that an important structural recovery is already underway.
Momentum Quality
RSI at 64.47 lies within Chanakya’s preferred momentum range of 56–68. It reflects buying strength without entering the conventional overbought zone above 70.
ADX at 46.28 confirms a powerful trend. DMI Plus at 33.91, against DMI Minus at only 9.62, shows decisive buyer dominance. Momentum is positive at 135.20, while the Parabolic SAR at Rs. 1,051.86 remains well below the market price.
MACD is positive at 26.92, although it is marginally below the signal reading of 28.47, producing a histogram of -1.56. This signals a temporary pause in momentum rather than a confirmed reversal and supports the strategy of buying on dips or after breakout confirmation.
Key Price Zones
Immediate support is placed around Rs. 1,152–1,137, followed by stronger support at Rs. 1,115–1,104. Immediate resistance lies at Rs. 1,167–1,182. Above this zone, the important upside levels are Rs. 1,204, Rs. 1,249 and Rs. 1,286.
Final Verdict
TTK Healthcare qualifies as a high-conviction 4–6 week candidate because it combines strong ADX, favourable DMI, positive momentum and bullish moving-average alignment with a manageable RSI. Accumulate near Rs. 1,138–1,155 or buy after a sustained breakout above Rs. 1,168. Book partial profit at Rs. 1,205–1,249 and trail the balance towards Rs. 1,286–1,317.
Paresh Gordhandas View
TTK Healthcare offers one of the better risk-adjusted technical structures in the supplied list. The stock is strong but not excessively heated. Disciplined accumulation near support is preferable, while a close below Rs. 1,104 would invalidate the short-term bullish thesis.
TTK Healthcare Technical Dashboard
TTK Healthcare’s technical structure supports a 4–6 week bullish view, although entries should remain disciplined because the stock is approaching its upper Bollinger Band and short-term momentum readings are elevated.
Technical Indicators
| Indicator | Reading | Interpretation |
|---|---|---|
| RSI | 64.47 | Strong momentum; not overbought |
| MACD/Signal | 26.92/28.47 | Positive, but momentum has temporarily moderated |
| ADX | 46.28 | Very strong trend |
| DMI | +33.91/-9.62 | Buyers firmly control the trend |
| Stochastic | 71.37/47.15 | Upward momentum remains active |
| CCI | 132.08 | Bullish territory |
| ATR | Rs. 53.44 | Meaningful volatility; position sizing is essential |
| Parabolic SAR | Rs. 1,051.86 | Positional trend remains bullish |
| Momentum | 135.20 | Strong positive momentum |
MACD remains above zero, but its negative histogram of -1.56 shows temporary deceleration. This does not invalidate the bullish setup; it favours accumulation on declines instead of aggressive chasing.
Moving-Average Structure
The stock is trading above its 20-day SMA at Rs. 1,100.69, 34-day SMA at Rs. 1,068.97, 50-day SMA at Rs. 1,024.64 and 200-day SMA at Rs. 968.68. This alignment confirms a strong recovery, even though the 63-day trend classification remains bearish.
The Bollinger upper band at Rs. 1,165.88 is the immediate hurdle. Sustained trading above this level can trigger a fresh momentum expansion.
Key Technical Levels
| Level | Price |
|---|---|
| Pivot point | Rs. 1,155.43 |
| Immediate support | Rs. 1,152–1,145 |
| Strong support | Rs. 1,115–1,104 |
| Immediate resistance | Rs. 1,167–1,182 |
| Major resistance | Rs. 1,204–1,205 |
| Higher targets | Rs. 1,249/1,286/1,317 |
Execution Plan
Accumulate gradually around Rs. 1,138–1,155. Fresh breakout buying should be considered only after the stock sustains above Rs. 1,168 with healthy volume.
Book partial profit near Rs. 1,204–1,205 and trail the remaining position towards Rs. 1,249 and Rs. 1,286. If Rs. 1,249 is crossed decisively, the rally may extend towards Rs. 1,317.
Maintain a closing stop loss at Rs. 1,104 for accumulation positions. Breakout traders may use Rs. 1,137 as a tighter risk-control level.
Confidence Meter
Technical confidence: 8.5/10
The bullish moving-average structure, strong ADX and favourable DMI support the trade. The only caution comes from the mildly weakening MACD histogram and elevated Stochastic RSI.
Chanakya Trading Interpretation
TTK Healthcare remains suitable for patient swing traders seeking a technically strong but not excessively overheated stock. The best risk-reward lies in buying controlled declines or a confirmed breakout—not chasing an unsupported gap-up. A sustained close below Rs. 1,104 would weaken the bullish structure and require an exit or fresh review.